Prime Medicine (PRME) Other Operating Expenses (2023)
Prime Medicine's (PRME) quarterly Other Operating Expenses came in at $13.5 million in Q4 2023.
Analysis
Prime Medicine (PRME) Other Operating Expenses (2023) Analysis & Trends
Prime Medicine (PRME) has 1 years of Other Operating Expenses data on file, last reported at $13.5 million in Q4 2023.
- Quarterly Other Operating Expenses changed N/A year-over-year to $13.5 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $13.5 million (changed N/A YoY) and the FY2023 annual result came in at $13.5 million, changed N/A from the prior year.
- Other Operating Expenses was little changed at $13.5 million in Q4 2023.
- In the past five years, Other Operating Expenses ranged from a high of $13.5 million in Q4 2023 to a low of $13.5 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Prime Medicine | 653.96 Mn | 653.96 Mn | - |